Gyeonggi-do, South Korea

Nui Ha

This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Neuracle Science Co., Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nui Ha. Retrieved from https://idiyas.com/inventor/nui-ha

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Inventor Nui Ha

Introduction

Nui Ha is an accomplished inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of mood disorder treatment and diagnosis through his innovative research and patent.

Latest Patents

Nui Ha holds a patent for the "Use of anti-family with sequence similarity 19, member A5 antibodies for the treatment and diagnosis of mood disorders." This patent outlines a method for diagnosing mood disorders by measuring serum FAM19A5 concentration using an antagonist that specifically binds to FAM19A5. Additionally, it describes a treatment method involving the administration of an FAM19A5 antagonist to subjects in need.

Career Highlights

Nui Ha is associated with Neuracle Science Co., Ltd., where he continues to advance research in the field of mental health. His work focuses on innovative approaches to understanding and treating mood disorders, contributing to the overall improvement of mental health care.

Collaborations

Some of his notable coworkers include Jae Young Seong and Byung Joo Ham, who collaborate with him on various projects within the company.

Conclusion

Nui Ha's innovative work and patent in the treatment and diagnosis of mood disorders highlight his significant contributions to mental health research. His dedication to advancing this field is commendable and reflects the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…